1 |
Mandel ID. Sialochemistry in diseases and clinical situations affecting salivary glands. Crit Rev Clin Lab Sci 1980;12:321-366.
DOI
|
2 |
Sreebny LM. Xerostomia: diagnosis, management, clinical complications. In: Edgar WM, O'Mullane DM, eds. Saliva and oral health. 2nd ed. London: British Dental Association; 1996. pp. 43-46.
|
3 |
Ishii M, Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des 2006;12:3573-3581.
DOI
ScienceOn
|
4 |
Frydrych AM, Davies GR, Slack-Smith LM, Heywood J. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia. Aust Dent J 2002;47:249-253.
DOI
ScienceOn
|
5 |
Hamlar DD, Schuller DE, Gahbauer RA, et al. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 1996;106:972-976.
DOI
ScienceOn
|
6 |
Lockhart PB, Fox PC, Gentry AC, Acharya R, Norton HJ. Pilot study of controlled-release pilocarpine in normal subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:517-524.
DOI
ScienceOn
|
7 |
Berk L. Systemic pilocarpine for treatment of xerostomia. Expert Opin Drug Metab Toxicol 2008;4:1333-1340.
DOI
ScienceOn
|
8 |
Bernardi R, Perin C, Becker FL, et al. Effect of pilocarpine mouthwash on salivary flow. Braz J Med Biol Res 2002;35:105-110.
DOI
|
9 |
Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer. Aust Dent J 2006;51:333-337.
DOI
ScienceOn
|
10 |
Mikhail AR, inventor. Pilocarpine mouthwash for dry mouth relief. United States patent US 4,209,505. 1980 Jun 24.
|
11 |
Kim JH, Park JH, Kwon JS, Ahn HJ. Effect of pilocarpine mouthwash on xerostomia. Korean J Oral Med 2011;36:21-24.
|
12 |
Fox PC, Atkinson JC, Macynski AA, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991;151:1149-1152.
DOI
ScienceOn
|
13 |
Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995;49:143-155.
DOI
ScienceOn
|
14 |
Ferguson MM. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1993;75:186-191.
DOI
ScienceOn
|
15 |
Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 1997;37:571-575.
DOI
ScienceOn
|
16 |
Peters GR, Novak E, Batts DH, Bye A, Nichols DJ, Francom SF. Multiple-dose, double-blind, placebo controlled intravenous tolerance and pharmacokinetic study of trospectomycin sulfate (U-63, 366F) in healthy male volunteers. Int J Clin Pharmacol Ther Toxicol 1990;28:361-368.
|
17 |
Aromdee C, Ferguson MM, Ledger R, Wall J. A pilot study of the disposition of pilocarpine in plasma, saliva and urine after a single oral dose. Eur J Pharm Sci 1999;8:81-83.
DOI
ScienceOn
|
18 |
Hearnden V, Sankar V, Hull K, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 2012;64:16-28.
DOI
ScienceOn
|
19 |
Fox PC. Salivary enhancement therapies. Caries Res 2004;38:241-246.
DOI
ScienceOn
|
20 |
Fox PC, van der Ven PF, Baum BJ, Mandel ID. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1986;61:243-248.
DOI
ScienceOn
|
21 |
Salagen tablet. In: Physician's desk reference: PDR. 51th ed. Montvale: Medical Economics Books; 1997. pp. 1546-1547.
|
22 |
Aframian DJ, Helcer M, Livni D, Robinson SD, Markitziu A, Nadler C. Pilocarpine treatment in a mixed cohort of xerostomic patients. Oral Dis 2007;13:88-92.
DOI
ScienceOn
|
23 |
Tsifetaki N, Kitsos G, Paschides CA, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis 2003;62:1204-1207.
DOI
|